Protagonist Therapeutics Inc (PTGX)
Operating Expenses
$54.71M
Quarterly · Period ending: · USD
PTGX Operating Expenses
Latest reported$54.71Mperiod ending
Latest reported$54.71Mperiod ending
PTGX Quarterly Operating Expenses ($2.69M → $54.71M)
Quarterly operating expenses
High-resolution chart · PNG
PTGX operating expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 54,709,000 | |
| 59,609,000 | |
| 57,792,000 | |
| 51,133,000 | |
| 47,587,000 | |
| 47,631,000 | |
| 43,858,000 | |
| 46,128,000 | |
| 42,960,000 | |
| 48,644,000 | |
| 36,951,000 | |
| 38,326,000 | |
| 42,354,000 | |
| 36,021,000 | |
| 36,516,000 | |
| 32,303,000 | |
| 41,459,000 | |
| 46,000,000 | |
| 45,714,000 | |
| 44,212,000 | |
| 33,147,000 | |
| 30,210,000 | |
| 24,480,000 | |
| 20,886,000 | |
| 24,434,000 | |
| 23,344,000 | |
| 20,018,000 | |
| 21,308,000 | |
| 23,218,000 | |
| 16,208,000 | |
| 17,765,000 | |
| 15,506,000 | |
| 20,913,000 | |
| 19,010,000 | |
| 14,795,000 | |
| 13,761,000 | |
| 15,131,000 | |
| 14,273,000 | |
| 11,397,000 | |
| 7,138,000 | |
| 7,091,000 | |
| 7,040,000 | |
| 5,001,000 | |
| 4,021,000 | |
| 3,083,000 | |
| 2,689,000 |